These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21625107)

  • 1. Vitamin D receptor activation: clinical outcomes.
    Covic A; Apetrii M
    Contrib Nephrol; 2011; 171():166-171. PubMed ID: 21625107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation.
    Andress DL
    Kidney Int; 2006 Jan; 69(1):33-43. PubMed ID: 16374421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D receptor activation and cardiovascular disease.
    Gonzalez-Parra E; Rojas-Rivera J; Tuñón J; Praga M; Ortiz A; Egido J
    Nephrol Dial Transplant; 2012 Dec; 27 Suppl 4():iv17-21. PubMed ID: 23258805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of vitamin D receptor activators in peritoneal dialysis.
    Bover J; Lloret MJ; DaSilva I; Furlano M; Díaz M; Herreros A; Cozzolino M; Ballarín J
    Contrib Nephrol; 2012; 178():124-142. PubMed ID: 22652728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D treatment in chronic kidney disease.
    Andress DL
    Semin Dial; 2005; 18(4):315-21. PubMed ID: 16076355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.
    Sprague SM; Coyne D
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):512-8. PubMed ID: 20133492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D, vitamin D receptor and the importance of its activation in patients with chronic kidney disease.
    Bover J; Egido J; Fernández-Giráldez E; Praga M; Solozábal-Campos C; Torregrosa JV; Martínez-Castelao A
    Nefrologia; 2015; 35(1):28-41. PubMed ID: 25611831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of vitamin D in the pathogenesis of chronic kidney disease].
    Cozzolino M; Brunini F; Capone V; Ricca F; Kwaidri Y; Montanari E; Cusi D
    Recenti Prog Med; 2013 Jan; 104(1):33-40. PubMed ID: 23439539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Control of phosphorus and treatment with vitamin D in chronic kidney disease prior to the start of dialysis].
    Sánchez González MC; Fernandez Giraldez E; Valdivielso Revilla JM
    Nefrologia; 2008; 28 Suppl 5():39-45. PubMed ID: 18847419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of paricalcitol on left ventricular hypertrophy.
    Cozzolino M; Ronco C
    Contrib Nephrol; 2011; 171():161-165. PubMed ID: 21625106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention and treatment of secondary hyperparathyroidism in non-dialyzed patients with stage 3-5 chronic kidney diease].
    Cozzolino M; Olivi L; Voli E; Ciceri P; Brancaccio D
    G Ital Nefrol; 2009; 26 Suppl 49():S30-5. PubMed ID: 19941276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease and vitamin D: how much is adequate?
    Ruggiero M; Pacini S
    Kidney Int; 2009 Nov; 76(9):931-3. PubMed ID: 19829313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of vitamin D therapy on left ventricular structure and function - are these the underlying explanations for improved CKD patient survival?
    Covic A; Voroneanu L; Goldsmith D
    Nephron Clin Pract; 2010; 116(3):c187-95. PubMed ID: 20606478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D metabolism and vitamin D traditional and nontraditional, target organs: implications for kidney patients.
    Dusilová-Sulková S
    J Ren Care; 2009 Mar; 35 Suppl 1():39-44. PubMed ID: 19222730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease.
    Kalantar-Zadeh K; Kovesdy CP
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1529-39. PubMed ID: 19661219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D in Chronic Kidney Disease and Dialysis Patients.
    Jean G; Souberbielle JC; Chazot C
    Nutrients; 2017 Mar; 9(4):. PubMed ID: 28346348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D in patients with kidney disease: cautiously optimistic.
    Thadhani R; Wolf M
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):22-6. PubMed ID: 17200040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D and cardiovascular disease: update and outlook.
    Pilz S; Kienreich K; Tomaschitz A; Lerchbaum E; Meinitzer A; März W; Zittermann A; Dekker JM
    Scand J Clin Lab Invest Suppl; 2012; 243():83-91. PubMed ID: 22536768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor activation: implications for daily practice.
    Warnock DG
    Contrib Nephrol; 2011; 171():172-180. PubMed ID: 21625108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.